Know Labs (NYSEAMERICAN:KNW) Shares Up 3.8% – Still a Buy?

Know Labs, Inc. (NYSEAMERICAN:KNW)’s stock price was up 3.8% during trading on Monday . The stock traded as high as $2.17 and last traded at $2.1390. Approximately 612,050 shares were traded during mid-day trading, a decline of 86% from the average daily volume of 4,376,964 shares. The stock had previously closed at $2.06.

Know Labs Trading Up 3.8%

The firm has a 50-day simple moving average of $2.14 and a two-hundred day simple moving average of $2.14. The company has a market capitalization of $16.04 million, a price-to-earnings ratio of -0.33 and a beta of 1.83.

Institutional Inflows and Outflows

An institutional investor recently bought a new position in Know Labs stock. Corient Private Wealth LLC purchased a new stake in Know Labs, Inc. (NYSEAMERICAN:KNW) in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 50,000 shares of the company’s stock, valued at approximately $99,000. Corient Private Wealth LLC owned 0.67% of Know Labs at the end of the most recent quarter. Hedge funds and other institutional investors own 23.96% of the company’s stock.

Know Labs Company Profile

Know Labs, Inc (NYSE American: KNW) is a life sciences company developing non‐invasive sensing solutions based on its proprietary Bio‐RFID platform. The technology employs low‐power radio‐frequency spectroscopy to scan the skin, enabling the detection of biochemical markers such as blood glucose, hydration levels and alcohol concentration without the need for blood draws or fingersticks. By applying sophisticated signal‐processing algorithms to reflected electromagnetic waves, the company aims to deliver real‐time, continuous monitoring devices that could transform standard practices in healthcare and wellness.

The company is focused on advancing its flagship prototype devices through clinical validation studies and regulatory pathways.